Viewing Study NCT01278160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-27 @ 11:23 PM
Study NCT ID: NCT01278160
Status: COMPLETED
Last Update Posted: 2014-10-27
First Post: 2011-01-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
Sponsor: Novo Nordisk A/S
Organization: